Featured News

Event Recap: RESI SF 2017

Networking on Steroids: Early stage entrepreneurs speed date with investors at RESI in San Francisco

By Marie Daghlian

You have 30 minutes per meeting, enough time to make your pitch, find out if there is a potential connection, and move on to the next meeting. It’s networking on steroids and it works for many of those who participate in RESI, or Redefining Early Stage Investments.

RESI makes it easy to partner and quickly allow early stage life sciences entrepreneurs to quickly identify whether an investor is interested in their technology or product…

Read More

RESI Innovators Shine in San Francisco – Winners Announced

The third RESI San Francisco Conference event, held on January 10th, saw 30 Innovation Challenge finalists competing for the votes of the largest RESI crowd to date. With 1,000 attendees present, more votes were cast than in any Innovation Challenge to date. Biotech, medical device, diagnostic and digital health companies all competed in the exhibition-style challenge for the top prize. Selected from over 100 applicants, the 30 finalists included many phenomenal startups. Here, LSN would like to present the 3 winners.

First Place: Pathcore (Toronto, Canada)…

Read More

RESI X Innovation Challenge – Winners Announced

On September 13, a record number of 700 entrepreneurs and investors entered the exhibition hall at Westin Copley Place, Boston, MA. They were greeted by 30 Innovation Challenge finalists—companies from the biopharma, biotech, medical device, diagnostics, and digital health sectors. The teams were screened and selected from over a hundred applicants; all were very strong competitors, but only one winner could emerge from the all-day exhibition-style contest!

First Place: BioMedomics, Inc. (Durham, NC, USA)…

Read More

MaRS HealthKick Innovation Challenge – Winners Announced

Last week at RESI on MaRS, the MaRS HealthKick Innovation Challenge showcased 30 companies from the digital health, biotech, medical device and diagnostics sectors. These companies were screened and selected from over a hundred applicants; all were very strong competitors, but only one winner could emerge from the all-day exhibition-style contest. Here are the top 4 entrants, with a tie for third place!

First Place: Perimeter Medical Imaging (Toronto, Canada)…

Read More

MaRS Collaborates with Life Science Nation and Johnson & Johnson Innovation to Host RESI in Toronto

TORONTO, April 12, 2016 — MaRS Discovery District (MaRS) is collaborating with Life Science Nation (LSN) and Johnson & Johnson Innovation, JLABS (JLABS) to bring the Redefining Early Stage Investments (RESI) Conference to Toronto on June 23, 2016.

The RESI Conference series brings together fundraising CEOs and early-stage investors from around the globe, providing the opportunity for dialogue and relationship building…

Read More

There’s More To January Than Just the JPM Conference

One of the biggest biopharmaceutical industry events, the 34th Annual JP Morgan Healthcare Conference, is right around the corner, January 11-14. And while the event is famous for overrunning San Francisco with neckties, as well as blowing up Twitter with its hashtag #JPM2016, there are a number of other worthwhile events also taking place, such as Life Science Nation’s Redefining Early Stage Investments (RESI) conference.

To RESI Or Not To RESI, Not Really A Question…

Read More

RESI Innovation Challenge Winners Announced

Yesterday, the sixth Redefining Early Stage Investments (RESI) Conference was held at the Westin Copley Place, Boston. Featuring approximately 200 investors, 250 biotech, medtech and healthcare IT entrepreneurs, and 130 service providers, this event is the biggest RESI ever.

In the exhibit hall, 30 of the most innovative early stage life science companies at the event were chosen to participate in a virtual investment contest – The RESI Innovation Challenge, showcasing cutting-edge life science technologies in poster displays and competing to raise the most RESI Cash. Without further ado here are the top 3 contestants!

First Prize Winner: Rna Diagnostics…

Read More

Update from LSN

Life Science Nation (LSN) will be hosting the Redefining Early Stage Investments (RESI) conference in collaboration with Johnson & Johnson Innovation, JLABS (JLABS) on September 16th in Boston. JLABS will be hosting a cocktail reception to wrap up the event.

“The JLABS event will provide a great venue for scientist-entrepreneurs and investors to get some additional networking time,” said Dennis Ford, CEO, LSN.

Read More

Back to Boston and Bigger than Ever: RESI Conference on September 16th

The first Redefining Early Stage Investments (RESI) Conference took place on September 16, 2013, and two years later, following highly successful events in San Francisco and Houston, we return to Boston for the sixth RESI Conference. With new and returning sponsors including Johnson & Johnson Innovation JLABS, Charles River Laboratories, McDermott Will & Emory, and Wuxi AppTec, we expect this event to be the largest RESI so far, with more content and more meetings than ever.

Read More

New Conference Focused on Early-Stage Funding Comes to Houston

The Texas Medical Center plans to host an international conference this summer to help match investors and life science CEOs. The Redefining Early Stage Investment Conference, or RESI, will take place June 8 at TMCx, the Texas Medical Center’s new accelerator and co-working space.

RESI, based out of Boston, plans to feature a variety of investor-types, including angels, venture capitalists, private endowments and corporate venture arms looking for new technology to invest in, according to a statement…

Read More